The advances in research on phosphorylation of polyglutamine disease

Chinese Journal of Medical Genetics

Volumn 25, Issue 4, 2008, Pages 414-417

  Zhou, Ya Fang ^a   Jiang, Hong ^a   Tang, Jian Guang ^b   Tang, Bei Sha ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Nuclear inclusion; Phosphorylation; Polyglutamine diseases

Indexed keywords

POLYGLUTAMINE;

DEGENERATIVE DISEASE; GENETIC DISORDER; HUNTINGTON CHOREA; PATHOGENESIS; POLYGLUTAMINE DISEASE; PROTEIN PHOSPHORYLATION; REVIEW;

HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM; HUMANS; HUNTINGTON DISEASE; MACHADO-JOSEPH DISEASE; MUSCULAR ATROPHY, SPINAL; PEPTIDES; PHOSPHORYLATION; SPINOCEREBELLAR DEGENERATIONS; TRINUCLEOTIDE REPEAT EXPANSION; TRINUCLEOTIDE REPEATS;

EID: 50249142475     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Gatchel JR, Zoghbi HY. Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet, 2005, 6:743-755.
2. Schols L, Amoiridis G, Buttner T, et al. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann Neurol, 1997, 42:924-932.
3. Tang BS, Liu C, Shen L, et al. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients widi hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol, 2000, 57:540-544.
4. Hunter T. Signaling-2000 and beyond. Cell, 2000, 100:113-127.
5. Chen HK, Fernandez-Funez P, Acevedo SF, et al. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell, 2003, 113:457-468.
6. Emamian ES, Kaytor MD, Duvick LA, et al. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron, 2003, 38:375-387.
7. Vierra-Green CA, Orr HT, Zoghbi HY, et al. Identification of a novel phosphorylation site in ataxin-1. Biochim Biophys Acta, 2005, 1744:11-18.
8. Yazawa I, Hazeki N, Nakase H, et al. Histone H3 is aberrantiy phosphorylated in glutamine-repeat diseases. Biochem Biophys Res Commun, 2003, 302:144-149.
9. Sharp AH, Loev SJ, Schilling G, et al. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron, 1995, 14:1065-1074.
10. Luo S, Vacher C, Davies JE, et al. Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity. J Cell Biol, 2005, 169:647-656.
11. Warby SC, Chan EY, Metzler M, et al. Huntingtin phosphorylation on serine 421 is significandy reduced in the striatum and by polyglutamine expansion in vivo. Hum Mol Genet, 2005, 14:1569-1577.
12. Humbert S, Bryson EA, Cordelières FP, et al. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev Cell, 2002, 2:831-837.
13. Rangone H, Pardo R, Colin E, et al. Phosphorylation of arfaptin 2 at Ser260 by Akt inhibits polyQ huntingtin-induced toxicity by rescuing proteasome impairment. J Cell Biol, 2005, 280:22021-22028.
14. Pardo R, Colin E, Regulier E, et al. Inhibition of calcineurin by FK506 protects against Polyglutamine-Huntingtin toxicity through an increase of Huntingtin Phosphorylation at S421. J Neurosci, 2006, 26:1635-1645.
15. Song C, Zhang Y, Parsons CG, et al. Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-D-aspartate receptors. J Biol Chem, 2003, 278:33364-33369.
16. Nagafuchi S, Yanagisawa H, Sato K, et al. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet, 1994, 6:14-18.
17. Okamura-Oho Y, Miyashita T, Nagao K, et al. Dentatorubral- pallidoluysian atrophy protein is phosphorylated by c-Jun NH2-terminal kinase. Hum Mol Genet, 2003, 12:1535-1542.
18. Belsham DD, Yee WC, Greenberg CR, et al. Analysis of the CAG repeat region of the androgen receptor gene in a kindred with X-linked spinal and bulbar muscular atrophy. J Neurol Sci, 1992, 112:133-138.
19. LaFevre-Bernt MA, Ellerby LM. Kennedy's disease. Phosphorylation of the polyglutamine-expanded form of androgen receptor regulates its cleavage by caspase-3 and enhances cell death. J Biol Chem, 2003, 278:34918-34924.
20. Banfi S, Servadio A, Chung MY, et al. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet, 1994, 7:513-520.
21. Kaytor MD, Byam CE, Tousey SK, et al. A cell-based screen for modulators of ataxin-1 phosphorylation. Hum Mol Genet, 2005, 14:1095-1105.
22. Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32. 1. Nat Genet, 1994, 8:221-228.
23. Fei E, Jia N, Zhang T, et al. Phosphorylation of ataxin-3 by glycogen synthase kinase 3b at serine 256 regulates the aggregation of ataxin-3. Biochem Biophys Res Commun, 2007, 357:487-492.
24. Ellisdon AM, Thomas B, BottomLey SP. The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step. J Biol Chem, 2006, 281:16888-16896.
25. Tanaka M, Machida Y, Nishikawa Y, et al. Expansion of polyglutamine induces the formation of quasi-aggregate in the early stage of protein fibrillization. J Biol Chem, 2003, 278:34717-34724.
26. Cowan KJ, Diamond MI, Welch WJ. Polyglutamine protein aggregation and toxicity are linked to the cellular stress response. Hum Mol Genet, 2003, 12:1377-1391.
27. Kitamura A, Kubota H, Pack CG, et al. Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nat Cell Biol, 2006, 8:1163-1170.